Literature DB >> 2440902

Interferon assay as a viral diagnostic test.

S J Skidmore, M J Jarlow.   

Abstract

The early production of interferons (IFNs) following viral infection has led to their detection being investigated as a method of diagnosis of such infections. The assay described here for alpha-IFN can be completed in one day and therefore has advantages over previously used bioassays. However, because production of IFN is transient, collection of samples must be soon after the onset of illness. For this reason the assay is more useful in cases where patients are seen early after the onset of symptoms. We have been looking at several such groups; the one reported here is children admitted to a paediatric infectious disease unit. 24/34 sera where a virus was found were positive for IFN and 14/52 where no virus was isolated. Control sera and those from patients with a bacterial infection were negative for IFN. We feel that the test is useful for certain groups of patients and are continuing to assess the assay for inclusion as a routine diagnostic test.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440902     DOI: 10.1016/0166-0934(87)90040-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

1.  Dynamic changes in inflammatory cytokines in pigs infected with highly pathogenic porcine reproductive and respiratory syndrome virus.

Authors:  Yonggang Liu; Wenda Shi; Enmin Zhou; Shujie Wang; Shouping Hu; Xuehui Cai; Fulong Rong; Jiabin Wu; Min Xu; Mingming Xu; Liqin Li
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

2.  Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine.

Authors:  D A Boldy; S J Skidmore; J G Ayres
Journal:  Respir Med       Date:  1990-09       Impact factor: 3.415

3.  Respiratory viral infections drive different lung cytokine profiles in pigs.

Authors:  Hanna Turlewicz-Podbielska; Ewelina Czyżewska-Dors; Małgorzata Pomorska-Mól
Journal:  BMC Vet Res       Date:  2021-01-06       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.